Browse bills
HR 4278
To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.
In Committee
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Sponsors
Official sponsors from legislative records.
Primary sponsor
Gregory Murphy
HouseNCRepublicanDistrict 3
Cosponsor
Diana Harshbarger
HouseTNRepublicanDistrict 1
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.